|
Annals of the New York Academy of Sciences
Annals
In this Annals volume experts discuss the latest advances in biomarker technologies and biomarker development for brain disorders.
Recent Annals
November 2009
Edited by Simon Lovestone (King's College, University of London)
Experts discuss the latest advances in biomarker technologies and biomarker development for brain disorders, and the logistical, regulatory, and funding challenges experienced by scientists working on clinical trials for biomarkers.
Full Text
November 2009
Edited by Lewis L. Judd (Department of Psychiatry, University of California, San Diego) and Esther Sternberg (Integrative Neural Immune Program, Section on Neuroendocrine Immunology and Behavior, NIMH, NIH, Bethesda, Maryland)
New basic research provides important insights into possible mechanisms of action that promote negative sequelae in vulnerable and susceptible patients who receive glucocorticoid treatment.
Full Text
October 2009
Edited by Chris Peers (School of Medicine, University of Leeds, Leeds, UK), Gabriel G. Haddad (University of California, San Diego, California), and Navdeep S. Chandel (Northwestern University, Evanston, Illinois)
This volume explores the transcriptional and pathophysiological responses to hypoxia and of the sensing mechanisms responsible for detection of oxygen level changes in the body.
Full Text
October 2009
Edited by Günther Witzany (Telos-Philosophische Praxis, Bürmoos, Austria)
Scientists working on genome organization, genome restructuring, genome formatting, and virus research discuss how to integrate these discoveries into the basic understanding of evolution, development, and disease.
Full Text
September 2009
Edited by Lothar Kanz and Katja C. Weisel (University of Tübingen, Tübingen, Germany), John E. Dick (University of Toronto, Toronto, Ontario, Canada), and Willem E. Fibbe (Leiden University Medical Center, Leiden, The Netherlands)
A fundamental property of hematopoetic stem cells is the capacity to self-renew; this volume presents recent developments and clinical implications in hematopoietic stem cell research.
Full Text
September 2009
Edited by John Rossi (Beckman Research Institute of the City of Hope, Duarte, California), Michael Gait (Medical Research Council, Cambridge, UK), and Fritz Eckstein (Max-Planck Institute for Experimental Medicine, Göttingen, Germany)
Basic researchers in molecular biology, cell biology, nucleic acid chemistry, pharmacology, and applied therapeutics present new technologies in the field of oligonucleotide research.
Full Text
September 2009
Edited by Ralph Steinman (The Rockefeller University, New York, New York), Jacques Banchereau (Baylor Institute for Immunology Research, Dallas, Texas), and Olivera J. Finn (School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania)
From world-renowned researchers and clinicians, manuscripts in this volume shed light on recent steps forward in immunotherapeutic and preventive approaches for future cancer vaccines.
Full Text
September 2009
Edited by Aftab Ansari, Abdul Jabbar, Tristram Parslow, and Rafi Ahmed (Emory University, Atlanta, GA)
Leaders in the field cover basic biology, pathogenesis, epidemiology and immunology of pathogenic hemorrhagic fever arenaviruses such as dengue virus, Rift Valley fever virus, Pichinde virus, and hantavirus.
Special online volume with free access to all articles
Full Text
September 2009
Edited by Gerard Karsenty (Columbia University, New York, New York)
Contributions from top researchers summarize the state of the art in the field of integrative physiology and speculate on how the field might move forward.
Special online volume
Full Text
September 2009
Edited by Yehuda Shoenfeld (Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel) and M. Eric Gershwin (University of California, Davis, California)
Covering a wide range of topics in autoimmune research, manuscripts herein are from attendees of the 6th International Congress of Autoimmunity.
Full Text
|
|